Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer

Japanese Journal of Clinical Oncology

Volumn 33, Issue 7, 2003, Pages 341-345

  Nishimura, Yasumasa ^a   Koike, Ryuta ^a   Nakamatsu, Kiyoshi ^a   Kanamori, Shuichi ^a   Suzuki, Minoru ^a,b   Shigeoka, Hironori ^a   Shiozaki, Hitoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Chemotherap; Esophageal cancer; Loco regional recurrenc; Radiotherapy; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN; ANTINEOPLASTIC AGENT; CF REGIMEN;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG INFUSION; DYSPHAGIA; ESOPHAGUS CANCER; FEASIBILITY STUDY; FEMALE; FEVER; HUMAN; HYPERKALEMIA; LEUKOPENIA; LIVER TOXICITY; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; NEPHROTOXICITY; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; RADIATION DOSE FRACTIONATION; SKIN TOXICITY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; DRUG ADMINISTRATION; ESOPHAGUS TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POSTOPERATIVE PERIOD;

EID: 0141817905     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg065     Document Type: Article

References (14)

1. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle JS, Vaitkevicius VK, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
2. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An Intergroup study. J Clin Oncol 1997;15:277-84.
3. Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:269-76.
4. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74.
5. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999;17:2915-21.
6. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 2002;53:134-9.
7. Bhansali MS, Fujita H, Kakegawa T, Yamana H, Ono T, Hikita S, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997;21:275-81.
8. Nemoto K, Ariga H, Kakuto Y, Matsushita H, Takeda K, Takahashi C, et al. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiother Oncol 2001;61:165-8.
9. Raoul JL, Le Prise E, Meunier B, Julienne V, Etienne PL, Gosselin M, et al. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut 1995;37:174-6.
10. Sakai K, Inakoshi H, Sueyama H, Oda J, Ito T, Tsuchida E, et al. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31:921-7.
11. Nemoto K, Matsushita H, Ogawa Y, Takeda K, Takahashi C, Britton KR, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer. Am J Clin Oncol 2003;26:46-9.
12. Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, et al. Phase I study and pharmacological analysis of cis-diammine (glycolato) platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Cancer Res 1991;51:1472-7.
13. Koide N, Hiraguri M, Nishio A, Hanazaki K, Adachi W, Shikama N, et al. Ulcer in the gastric tube for esophageal replacement: A comparison of 12 esophageal cancer patients with or without postoperative radiotherapy. J Gastroenterol Hepatol 2001;16:137-41.
14. Zieren HU, Muller JM, Jacobi CA, Pichlmaier H, Muller RP, Staar S. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study. World J Surg 1995;19:444-9.